Kentucky sues Optum Rx for allegedly fueling opioid crisis with reckless practices

Kentucky has taken legal action against Optum Rx, a major pharmacy benefit manager, for its alleged role in fueling the opioid crisis. Attorney General Russell Coleman filed the lawsuit, accusing the company of recklessly promoting and oversupplying opioids across the state. The move comes as Kentucky continues to grapple with the devastating effects of drug overdoses, including nearly 2,000 deaths in 2021 alone.

The lawsuit builds on a previous complaint from September 2022, which targeted Express Scripts and related entities. Optum Rx, a subsidiary of UnitedHealth Group, manages a vast network of around 67,000 retail pharmacies nationwide. According to the Attorney General's Office, the company used opaque business practices and strict confidentiality agreements to conceal its involvement in the opioid supply chain.

Optum Rx is accused of working closely with opioid manufacturers, pharmacies, and insurers to push excessive prescriptions. The lawsuit claims the company played a central role in creating an oversupply of the drugs, worsening Kentucky's addiction crisis. Attorney General Coleman has also stressed that funds recovered from earlier opioid settlements are being directed toward youth prevention programmes. One such initiative is the *Better Without It* campaign, a two-year, £3.6 million effort to educate young people about the dangers of drug misuse. The state's legal action marks the first time a U.S. state has pursued a pharmacy benefit manager in this way for its alleged contribution to the opioid epidemic.

The lawsuit seeks to hold Optum Rx accountable for its alleged role in the crisis. If successful, the case could set a precedent for how states address the responsibilities of pharmacy benefit managers in the opioid epidemic. Kentucky's ongoing prevention efforts, meanwhile, aim to reduce future harm by targeting youth education.